Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) Return on Equity

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s return on equity stands at -544.04%. That is below the Healthcare sector average of -75.84%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) sits lower the Healthcare benchmark (-75.84%) with a ROE of -544.04%. That is roughly 617.4% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of -544.04% for Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s ROE evolved across reporting periods, while the comparison chart places IINNW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, ROE is commonly used to spot outliers. Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s reading of -544.04% (sector avg -75.84%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.